MARATTO

article

OP014 Does iPACK a punch? A prospective observational study on the efficacy of pain relief and functional improvement of an iPACK block for chronic knee osteoarthritis

Abstract

<h3></h3> <b>Please confirm that an ethics committee approval has been applied for or granted</b>: Yes: I’m uploading the Ethics Committee Approval as a PDF file with this abstract submission <h3>Background and Aims</h3> Knee osteoarthritis (KOA) causes chronic pain, which impairs mobility. Access to total knee replacement surgery is limited in lower- and middle-income countries, with waiting times often extending to many years. Prolonged immobility is associated with increased perioperative complications. Reducing patients’ chronic knee pain whilst awaiting surgery may therefore improve their mobility and surgical outcomes. This study investigated if pain and physical function were improved in patients with KOA, awaiting knee arthroplasty, using an iPACK (infiltration between the Popliteal Artery and the posterior Capsule of the Knee) block. <h3>Methods</h3> Nineteen patients with KOA attending a specialist Pain Unit in South Africa were included in the study. Baseline measurements of pain and physical function were performed using the numerical rating scale (NRS) and Knee Injury and Osteoarthritis Outcome Score short form (KOOS-PS). An ultrasound-guided iPACK block was performed, using 20ml 0.25% bupivacaine and 80mg methylprednisolone. Repeat NRS and KOOS-PS measurements were obtained telephonically after one and two months, and in-person at three months. <h3>Results</h3> Pain scores were significantly reduced at one month (NRS -2, p=0.044) and two months (NRS -2, p=0.021) but not month three. Similarly, physical function was significantly improved at month one (KOOS-PS -7.6, p=0.016), and month two (KOOS-PS -10.2, p=0.026) but not month three. Most participants (78.9%) reported satisfaction with the block. <h3>Conclusions</h3> An iPACK block reduces chronic pain and improves physical function in patients awaiting knee arthroplasty, for about two months. Larger studies are required to confirm these findings and if these translate to reduced perioperative complications.

Research topics

  • Cancer Treatment and Pharmacology
  • Inflammatory mediators and NSAID effects
  • Pharmacology and Obesity Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1136/rapm-2024-esra.14

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.